Treatment Effectiveness and Side Effects: A Model of Physician Learning

Full terms and conditions of use:

[1]  Richard E. Caves,et al.  Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals , 1988, The Journal of Law and Economics.

[2]  Gregory S. Crawford,et al.  Uncertainty and Learning in Pharmaceutical Demand , 2005 .

[3]  J. M. Villas-Boas,et al.  Dynamic Competition with Experience Goods , 2006 .

[4]  J. M. Villas-Boas.  Consumer Learning, Brand Loyalty, and Competition , 2004 .

[5]  M. Degroot.  Optimal Statistical Decisions , 1970 .

[6]  Andrew T. Ching,et al.  Consumer Learning and Heterogeneity: Dynamics of Demand for Prescription Drugs after Patent Expiration , 2001 .

[7]  Steven Berry,et al.  Differentiated Products Demand Systems from a Combination of Micro and Macro Data: The New Car Market , 1998, Journal of Political Economy.

[8]  Peter E. Rossi,et al.  Response Modeling with Nonrandom Marketing-Mix Variables , 2004 .

[9]  I. Goldstein,et al.  Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. , 1998, The New England journal of medicine.

[10]  J. M. Villas-Boas,et al.  Endogeneity in Brand Choice Models , 1999 .

[11]  Andrew T. Ching,et al.  Measuring the Informative and Persuasive Roles of Detailing on Prescribing Decisions , 2010, Manag. Sci..

[12]  W. Hellstrom,et al.  Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. , 2002, Journal of andrology.

[13]  M. Keane,et al.  Decision-Making Under Uncertainty: Capturing Dynamic Brand Choice Processes in Turbulent Consumer Goods Markets , 1996 .

[14]  Toker Doganoglu,et al.  Switching costs, experience goods and dynamic price competition , 2010 .

[15]  P. Klemperer.  Markets with consumer switching costs , 1986 .

[16]  Andrew T. Ching,et al.  The effects of detailing on prescribing decisions under quality uncertainty , 2009 .

[17]  Sridhar Narayanan,et al.  Heterogeneous Learning and the Targeting of Marketing Communication for New Products , 2009, Mark. Sci..

[18]  B. Hamilton,et al.  Learning, Private Information, and the Economic Evaluation of Randomized Experiments , 2003, Journal of Political Economy.

[19]  Melvyn Weeks,et al.  Discrete choice methods with simulation, Kenneth E. Train, Cambridge University Press, 2003, ISBN: 0-521-81696-3, pp. 334 , 2003 .

[20]  Ying Xie,et al.  The Role of Targeted Communication and Contagion in Product Adoption , 2008, Mark. Sci..

[21]  David Kjellberg.  Measuring Expectations , 1999, Identification Problems in the Social Sciences.

[22]  Jeffrey B. Gross,et al.  Timing of New Black Box Warnings and Withdrawals for Prescription Medications , 2003 .

[23]  K. Leffler,et al.  Persuasion or Information? The Economics of Prescription Drug Advertising , 1981, The Journal of Law and Economics.

[24]  Daniel A. Ackerberg.  Empirically Distinguishing Informative and Prestige Effects of Advertising , 2001 .

[25]  Pradeep Chintagunta,et al.  Information, learning, and drug diffusion: The case of Cox-2 inhibitors , 2008 .

[26]  Michael P. Keane,et al.  A model of health plan choice:: Inferring preferences and perceptions from a combination of revealed preference and attitudinal data , 1998 .

[27]  T. Costigan,et al.  Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. , 2002, The Journal of urology.

[28]  P. Klemperer.  Competition when Consumers have Switching Costs: An Overview with Applications to Industrial Organization, Macroeconomics, and International Trade , 1992 .

[29]  Paul Klemperer,et al.  Welfare Effects of Entry Into Markets with Switching Costs , 1988 .

[30]  P. Klemperer,et al.  Multi-Period Competition with Switching Costs , 1992 .